Renal Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients clinically diagnosed with stage T1a renal cell carcinoma, regardless of gender; 2.18 Age <=80 years old; 3. The RENAL score is low complexity (4-6 points); 4. Be capable of conducting regular follow-ups; 5. The patient and their family members expressed their knowledge of this study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Refuse to undergo radiofrequency ablation treatment or robotic partial nephrectomy, or plan to undergo radical nephrectomy or other surgical treatment methods; 2. Patients who refuse to have their data collected; 3. Patients with other concurrent tumors; 4. Patients with severe decompensated underlying heart and lung diseases, severe bleeding tendency diseases and other surgical contraindications; 5. Pregnant or lactating women; 6. The patient and his/her family refused to participate in this study. 7. Situations that the researcher deems necessary to exclude.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score;Resume daily activity time;Postoperative hospital stay;Operation time;Intraoperative and postoperative adverse events (contrast agent allergy, bleeding, infection, etc.); | — |
Countries
China
Contacts
Peking University First Hospital